Skip to main content

Ingalls & Snyder LLC

SEC CIK
0001041885
Latest filing
Aug 14, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Ingalls & Snyder LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
135,858
Value
$34.2M
% of portfolio
0.9%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Ingalls & Snyder LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026135,858$34.2M0.9%−3,769−2.7%ReducedHolders
Q1 2026139,627$30.4M1.1%−857−0.6%ReducedHolders
Q4 2025140,484$32.1M1.2%−4,543−3.1%ReducedHolders
Q3 2025145,027$33.6M1.1%+7,966+5.8%AddedHolders
Q2 2025137,061$25.4M0.9%+344+0.3%AddedHolders
Q1 2025136,717$28.6M0.9%−1,031−0.7%ReducedHolders
Q4 2024137,748$24.5M1.0%−1,892−1.4%ReducedHolders
Q3 2024139,640$27.6M1.1%−9,823−6.6%ReducedHolders
Q2 2024149,463$25.6M1.1%−2,516−1.7%ReducedHolders
Q1 2024151,979$27.7M1.2%−2,588−1.7%ReducedHolders
Q4 2023154,567$24.0M1.1%−9,198−5.6%ReducedHolders
Q3 2023163,765$24.4M1.2%−3,258−2.0%ReducedHolders
Q2 2023167,023$22.5M1.1%−1,363−0.8%ReducedHolders
Q1 2023168,386$26.8M1.4%−380.0%ReducedHolders
Q4 2022168,424$27.2M1.5%−1,837−1.1%ReducedHolders
Q3 2022170,261$22.9M1.3%−1,255−0.7%ReducedHolders
Q2 2022171,516$26.3M1.4%−2,594−1.5%ReducedHolders
Q1 2022174,110$28.2M1.3%−8,749−4.8%ReducedHolders
Q4 2021182,859$24.8M1.1%+3,044+1.7%AddedHolders
Q3 2021179,815$19.4M0.9%−7,655−4.1%ReducedHolders
Q2 2021187,470$21.1M0.9%+549+0.3%AddedHolders
Q1 2021186,921$20.2M1.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.